Skip to main content

Day: August 4, 2020

Altair Announces Winners of 8th Annual Altair Enlighten Awards

TROY, Mich., Aug. 04, 2020 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global technology company providing solutions in product development, high-performance computing (HPC), and data analytics, is pleased to announce the winners of the 2020 Altair Enlighten Awards. Presented jointly with the Center for Automotive Research (CAR), the 8th Annual Enlighten Awards acknowledge the world’s best initiatives to reduce vehicle weight and meet emissions targets, inspiring breakthrough advancements that push the industry towards a more sustainable future.“As we sit at the crossroads of science, engineering, art, and design, creating a more sustainable future is the essence of Altair as we are a pioneer in lightweighting technologies and methodologies,” said James Scapa, founder and chief executive officer of Altair. “I am proud to see that...

Continue reading

Inphi Acquires Resources from Arrive Technologies to Expand Design Resource Infrastructure

SANTA CLARA, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Inphi Corporation (NYSE: IPHI), a leader in high-speed data movement interconnects, today announced that it has acquired certain assets from Arrive Technologies, located in Ho Chi Minh City, Vietnam. The addition of these resources will provide Inphi with front-end design, verification, validation and firmware skills that complement Inphi’s existing design teams in Singapore and Vietnam. Financial terms of the transaction were not disclosed.“Resource allocation for new projects is an industry challenge. With the acquisition of resources from Arrive, we are now able to dedicate a world-class engineering team to projects targeting our cloud and telecom customers,” said Ford Tamer, President and CEO of Inphi Corporation. “We welcome the team from Arrive to the Inphi family and are...

Continue reading

Akoustis to Participate in the 23rd Annual Oppenheimer Technology, Internet & Communications Conference on August 11, 2020

Charlotte, N.C., Aug. 04, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that management will attend the 23rd Annual Oppenheimer Technology, Internet & Communications Conference which will be held virtually on August 11-12, 2020.Meetings will take place virtually on August 11, 2020 given the ongoing call for social distancing due to the Covid-19 pandemic. Investors that would like to schedule a meeting with Akoustis management should contact their Oppenheimer sales representative or Akoustis’ investor relations at: ir@akoustis.com.Akoustis’ high frequency, high performance XBAW process and filters are experiencing growing...

Continue reading

Sprott Announces Date for 2020 Second Quarter Results Conference Call

TORONTO, Aug. 04, 2020 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE:SII) (TSX:SII) (“Sprott”) will host a conference call on Friday, August 7, 2020 at 10:00 a.m. ET to discuss its 2020 second quarter results.  Peter Grosskopf, CEO of Sprott will host the call with Whitney George, President of Sprott and Kevin Hibbert, CFO of Sprott. The Company plans to release its financial results at 7:00 a.m. ET the same day.Conference Call DetailsTo participate in the call, please dial (855) 458-4215 ten minutes prior to the scheduled start of the call and provide conference ID 8064077. A taped replay of the conference call will be available until Friday, August 14, 2020 by calling (855) 859-2056, reference number 8064077. The conference call will be webcast live at www.sprott.com and https://edge.media-server.com/mmc/p/wnaue4ybAbout SprottSprott is...

Continue reading

Canaan Inc. Announces the Appointment of Four Independent Directors to Enhance Its Corporate Governance

HANGZHOU, China, Aug. 04, 2020 (GLOBE NEWSWIRE) — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), a leading high-performance computing solutions provider, today announced that the terms of office of three of its independent directors, namely Mr. Hong Zhang, Mr. Xiaohu Yang, and Ms. Mei Luo, expired on August 1, 2020. All the departing independent directors will not seek appointments nor stand for elections to the board of directors of the Company (the “Board”) following the expiration of their respective terms of office.The nomination committee of the Board has confirmed the addition of Mr. Hongchao Du, Mr. Zhitang Shu, Mr. Wenjun Zhang and Ms. Yaping Zhang as independent directors to the Board, effective August 1, 2020.The nomination committee of the Board has examined the qualifications of the independent...

Continue reading

Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe

Amarin to Build Dedicated Organization to Retain Substantial Value of One of the Most Anticipated Cardiovascular Drug Products in DecadesVeteran Cardiovascular Commercial Executive Hired to Lead Focused LaunchDUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today announced the company’s plans to undertake its own focused commercial launch of VASCEPA® (icosapent ethyl) in Europe. Amarin’s plan is subject to review and approval of its Marketing Authorization Application (MAA) by the European Medicines Agency and the European Commission, respectively. The application is in the late stages of review for the reduction of cardiovascular (CV) risk in high-risk patients based on the REDUCE-IT® cardiovascular outcomes study. “With more than 80 million people in Europe with cardiovascular...

Continue reading

MediciNova to Participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

LA JOLLA, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference which will be held from September 14 – 18, 2020.  Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey O’Brien, JD/MBA, Vice President and Executive Officer, will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through Morgan Stanley.About MediciNovaMediciNova, Inc. is a publicly traded biopharmaceutical company focused on developing novel therapeutics for the treatment of diseases with high unmet medical needs...

Continue reading

SpringWorks Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference

STAMFORD, Conn., Aug. 04, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the 2020 Wedbush PacGrow Healthcare Conference on Tuesday, August 11, 2020 at 10:20 a.m. Eastern Standard Time.A video webcast will be available live on the “Events & Presentations” page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for approximately 30 days following the conference.About SpringWorks TherapeuticsSpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach...

Continue reading

Gold Standard Announces 2020 Phase 1 Development Program for the South Railroad Project, Carlin Trend, Nevada

Phase 1 to focus on Pinion oxide resource conversion and the South Railroad Feasibility StudyVANCOUVER, British Columbia, Aug. 04, 2020 (GLOBE NEWSWIRE) — Gold Standard Ventures Corp. (TSX: GSV; NYSE AMERICAN: GSV) (“Gold Standard” or the “Company”) today announced plans for the 2020 Phase 1 development and exploration program on its 100%-owned/controlled Railroad-Pinion Project in Nevada’s Carlin Trend.  The program includes an estimated 20,410 m of reverse-circulation (RC) and core drilling in 136 holes.  Three drill rigs are currently active on site at Pinion.The Phase 1 2020 program objectives are: (1) convert Pinion Phase 4 to Measured and Indicated confidence level (see attached Pinion Phase 1 drilling illustration); (2) drill test additional near-surface targets at Dark Star with the goal of expanding the oxide resource;...

Continue reading

Option Care Health Announces Financial Results for the Second Quarter

BANNOCKBURN, Ill., Aug. 04, 2020 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2020.Given the merger between HC Group Holdings II, Inc. (“Option Care”) and BioScrip, Inc. (“BioScrip”) to form Option Care Health on August 6, 2019, comparisons to historical periods are relative to legacy Option Care only and incorporate BioScrip results from August 6, 2019 prospectively. Further, as reported on February 3, 2020, the Company completed a reverse 1-for-4 stock split in the first quarter and, as a result, all per share data below is reported incorporating the effect of the reverse stock split as if it was effective for all periods...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.